The Center for BRCA and Related Genes provides expert clinical care to patients with BRCA-mutated and BRCA-related cancers, regardless of tumor type. We offer outstanding interdisciplinary, inter-disease group collaboration across multiple Dana-Farber disease centers.
AI-based cancer diagnostic tools have fit rather seamlessly into clinical practice. They have also hinted at the potential for AI to benefit patients in other…
AI-based cancer diagnostic tools have fit rather seamlessly into clinical practice. They have also hinted at the potential for AI to benefit patients in other…
As Chen Wen Ye nears five years of being cancer-free, Chen has committed herself to helping others facing such issues.
Dana-Farber gynecologic oncologists are working to reduce disparities by lowering the barriers patients face when trying to access screening and care.
Geriatricians in oncology specialize in managing the big picture for patients as they age.
While atypical moles are not cancerous, the presence of one can indicate a higher risk of melanoma.
Save your spot to chat with our team at this online event. Each text based chat lasts around 10 mins and you can join from…
Meet us in Providence, Rhode Island on May 4th We are excited to bring our NET Impact Thrivership & Research Education Patient Conference to Providence,…
In a new study, scientists at Dana-Farber and others have identified a small molecule that interacts with BAX in a way that alters BAX’s activity.
Follicular lymphoma is a slow-growing form of non-Hodgkin lymphoma (NHL) that arises in white blood cells called B lymphocytes.
